Results for “”

Entry Author Date Location
Blue Squad Aims to Bring Election Tech Up and Down the Ballot 03/06/19 National
Two Years and Done: FDA Commissioner Gottlieb To Resign 03/05/19 National
Tasso Gets $6M For Device That Lets Users Self-Collect Blood Samples 03/05/19 Seattle
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Retailers Turn to Analytics, 3D Tech to Promote Fit, Reduce Returns 03/04/19 National
Cybersecurity on Tap: Agenda for Cyber Madness in Boston April 8 03/04/19 Boston
After AGTC Deal Flops, Biogen Bets $800M on Gene Therapy Rival Nightstar 03/04/19 Boston
Privacy Watch: FTC, Facebook, EU, the Cloud Act, & More CA bills 03/04/19 San Francisco
SPECIAL REPORT: 2019 Biopharma Outlook – Facing an Uncertain Future 03/01/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Ex-Google CEO: New MIT College Could Help Shrink A.I. Talent Gap 02/28/19 Boston
7 Tips for Biotech Companies Seeking Capital in a Volatile Market 02/28/19 National
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans 02/28/19 San Francisco
Carmera, Toyota Research Institute Zoom Ahead on AV Mapping Project 02/28/19 Detroit Ann Arbor
With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases 02/28/19 San Francisco
Walmart’s Store No 8 Acquires Aspectiva to Bring A.I. to Shopping 02/27/19 National
Early-Stage VC Firm Sorenson Ventures Closes Inaugural Fund at $110M 02/27/19 San Francisco
Amazon, Google, Facebook Boosted 2018 Tech Hiring Spree in U.S. Hubs 02/27/19 National
Blackstone, Novartis Start Up Anthos With $250M and a Heart Drug 02/27/19 Boston
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Oyster Point Gets $93M To Clear Up Dry Eye With a Nasal Spray 02/26/19 New York
Ginkgo’s Motif Launches with $90M for Animal-Free Meat & Milk Proteins 02/26/19 Boston
Bill Maris’s VC Firm Section 32 Raises $200M for Second Fund 02/25/19 San Diego
Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy 02/25/19 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Merck Scooping Up Cancer Drug Developer Immune Design for $300M 02/21/19 New York
Menlo Ventures Devotes New $500M Fund to Mid-Stage Growth Companies 02/20/19 San Francisco
Former Avexis Exec Kamal Named 4D Molecular Chief Technical Officer 02/19/19 San Francisco
With New Data, Intercept On Track for First-Ever Approved NASH Drug 02/19/19 New York
Bill Maris Fund Section 32 Notches Two Wins with Life Science Exits 02/15/19 San Diego
Page 2 of 638 « previous page · next page »